Tipifarnib enhances anti-EGFR activity of cetuximab in non-HRas mutated head and neck squamous cell carcinoma cancer (HNSCC)
Titel:
Tipifarnib enhances anti-EGFR activity of cetuximab in non-HRas mutated head and neck squamous cell carcinoma cancer (HNSCC)
Auteur:
Shu, Lihua Wang, Dongsheng Nannapaneni, Sreenivas Sun, Youzhi Griffith, Christopher C. Wang, Xu Chen, Zhengjia Patel, Mihir El-Deiry, Mark Shin, Dong M Chen, Zhuo G Saba, Nabil F